Restriction of HIV-1 replication in macrophages and CD4+ T cells from HIV controllers
Open Access
- 28 July 2011
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 118 (4), 955-964
- https://doi.org/10.1182/blood-2010-12-327106
Abstract
How HIV controllers (HICs) maintain undetectable viremia without therapy is unknown. The strong CD8+ T-cell HIV suppressive capacity found in many, but not all, HICs may contribute to long-lasting viral control. However, other earlier defense mechanisms may be involved. Here, we examined intrinsic HIC cell resistance to HIV-1 infection. After in vitro challenge, monocyte-derived macrophages and anti–CD3-activated CD4+ T cells from HICs showed low HIV-1 susceptibility. CD4 T-cell resistance was independent of HIV-1 coreceptors and affected also SIVmac infection. CD4+ T cells from HICs expressed ex vivo higher levels of p21Waf1/Cip1, which has been involved in the control of HIV-1 replication, than cells from control subjects. However, HIV restriction in anti–CD3-activated CD4+ T cells and macrophages was not associated with p21 expression. Restriction inhibited accumulation of reverse transcripts, leading to reduction of HIV-1 integrated proviruses. The block could be overcome by high viral inocula, suggesting the action of a saturable mechanism. Importantly, cell-associated HIV-1 DNA load was extremely low in HICs and correlated with CD4+ T-cell permissiveness to infection. These results point to a contribution of intrinsic cell resistance to the control of infection and the containment of viral reservoir in HICs.Keywords
This publication has 53 references indexed in Scilit:
- CD4+ T cells from elite controllers resist HIV-1 infection by selective upregulation of p21Journal of Clinical Investigation, 2011
- Unstimulated Primary CD4 + T Cells from HIV-1-Positive Elite Suppressors Are Fully Susceptible to HIV-1 Entry and Productive InfectionJournal of Virology, 2011
- A high HIV DNA level in PBMCs at antiretroviral treatment interruption predicts a shorter time to treatment resumption, independently of the CD4 nadirJournal of Medical Virology, 2010
- A dominant block to HIV-1 replication at reverse transcription in simian cellsProceedings of the National Academy of Sciences, 2002
- Cellular inhibitors with Fv1-like activity restrict human and simian immunodeficiency virus tropismProceedings of the National Academy of Sciences, 2002
- The role of the cyclin-dependent kinase inhibitor p21 in apoptosis.2002
- Macrophages and HIV infection: therapeutical approaches toward this strategic virus reservoirAntiviral Research, 2002
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Characterization of High-Risk HIV-1 Seronegative HemophiliacsClinical Immunology, 2001
- Human Immunodeficiency Virus Type 1 Spinoculation Enhances Infection through Virus BindingJournal of Virology, 2000